Wednesday, June 10, 2026

Drug profile · INN

mometasone

mometasone (ELOCON) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd.

TGA: approved
Patents linked 0
Pipeline programs 10
News articles 0
Drug details — mometasone

Quick answer

mometasone (ELOCON) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd.

Key facts

INN mometasone
Brand ELOCON

Approval history

Authority Status Date
TGA approved

Pipeline programs

  1. 410701BS Phase 3 · Anaxis Pharma · Plaque psoriasis
  2. J2T-MC-KGBT Phase 3 · Eli Lilly and · Perennial Allergic Rhinitis (PAR)
  3. J2T-MC-KGBU Phase 3 · Eli Lilly and · Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
  4. Mometasone Furoate Nasal Spray, 50 mcg Phase 3 · Amneal Pharma Europe · Seasonal Allergic Rhinitis
  5. ACT18207 Phase 2 · Sanofi-Aventis U.S · Respiratory tract diseases
  6. Mometasone furoate Phase 2 · Teva Pharma · Seasonal Allergic Rhinitis
  7. The BiRCh Study Phase 2 · Insmed Incorporated · Chronic Rhinosinusitis without Nasal Polyps (CRSsNP)
  8. Mometasone furoate drug formulation (MFF) 1 Phase 1 · BRIGHT MINDS BIOSCIENCES · Hypersensitivity

Frequently asked questions

What is mometasone?

mometasone (ELOCON) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd.

What is the brand name for mometasone?

ELOCON is a marketed brand name for mometasone. Check FDA Drugs@FDA for the current US label holder and prescribing information.